Somerset Therapeutics Private Limited FDA Record
- Latest inspection OAI · Feb 21, 2025
- Last warning letter 2025
Somerset Therapeutics Private Limited has 5 FDA recalls, 10 inspections, 0 510(k) clearances and 3 compliance actions on record. FDA has issued 3 warning letters to Somerset Therapeutics Private Limited, the most recent on Sep 4, 2025. FDA has published 1 Form 483 for Somerset Therapeutics Private Limited.
- Latest recall
- D-0398-2026 · Feb 4, 2026 · filed under Somerset Therapeutics
- Latest recall under this name
- D-0354-2025 · Class II · Mar 21, 2025
- Latest inspection
- Feb 21, 2025 · OAI
Newer recall under related name Somerset Therapeutics: Feb 4, 2026, D-0398-2026.
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 5 | Nov 15, 2026 | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 10 | Nov 17, 2026 | Newest record Nov 9, 2026 | Current |
| Compliance actions | 3 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
Somerset Therapeutics Private Limited: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 1 | 1 | 1 | 5 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 1 | 0 | 0 | 0 | 0 |
| 2022 | 1 | 1 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 1 | 1 | 1 | 0 | 0 |
| 2019 | 1 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 0 | 0 | 0 |
| 2017 | 2 | 0 | 0 | 0 | 0 |
Reviewing Somerset Therapeutics Private Limited as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Somerset Therapeutics Private Limited yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Somerset Therapeutics Private Limited FDA Warning Letters
| Issued | Subject | Issuing office | Close-out letter |
|---|---|---|---|
| Sep 4, 2025 · Letter on fda.gov | CGMP/Finished Pharmaceuticals/Adulterated | Center for Drug Evaluation and Research (CDER) | |
| Aug 13, 2020 · Record page | |||
| Feb 23, 2012 · Record page |
Somerset Therapeutics Private Limited Form 483s
| Date | Document | FEI |
|---|---|---|
| Feb 21, 2025 · Document on fda.gov | 483 | 3003821988 |
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0354-2025 | Class II | Methocarbamol Injection USP 1,000 mg/10 mL (100 mg/mL), 10 mL Single Dose Vial, Rx Only… | Mar 21, 2025 |
| D-0357-2025 | Class II | Haloperidol Decanoate Injection 100mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured by: Somerset… | Mar 21, 2025 |
| D-0356-2025 | Class II | Haloperidol Decanoate Injection 50mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured by: Somerset… | Mar 21, 2025 |
| D-0358-2025 | Class II | Haloperidol Decanoate Injection, 100 mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured for… | Mar 21, 2025 |
| D-0355-2025 | Class II | Haloperidol Decanoate Injection 50mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured for: Somerset… | Mar 21, 2025 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Feb 21, 2025 | Bengaluru, India | Drugs | Official Action Indicated (OAI) | 3003821988 |
| Oct 27, 2023 | Bengaluru, India | Drugs | Voluntary Action Indicated (VAI) | 3003821988 |
| Apr 4, 2022 | Bengaluru, India | Drugs | Official Action Indicated (OAI) | 3003821988 |
| Feb 19, 2020 | Bengaluru, India | Drugs | Official Action Indicated (OAI) | 3003821988 |
| Jul 23, 2019 | Bengaluru, India | Drugs | Voluntary Action Indicated (VAI) | 3003821988 |
| Dec 5, 2017 | Bengaluru, India | Drugs | Voluntary Action Indicated (VAI) | 3003821988 |
| Apr 24, 2017 | Bengaluru, India | Drugs | No Action Indicated (NAI) | 3003821988 |
| Aug 20, 2013 | Bengaluru, India | Drugs | Voluntary Action Indicated (VAI) | 3003821988 |
| Sep 20, 2011 | Bengaluru, India | Drugs | Official Action Indicated (OAI) | 3003821988 |
| Mar 31, 2009 | Bengaluru, India | Drugs | Voluntary Action Indicated (VAI) | 3003821988 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
Compliance Actions
FDA's compliance actions data lists 3 compliance actions under Somerset Therapeutics Private Limited: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3003821988 | Bengaluru, India | 10 | Feb 21, 2025 |
Somerset Therapeutics Private Limited and the FDA: common questions
Has Somerset Therapeutics Private Limited received an FDA warning letter?
Yes. FDA has issued 3 warning letters to Somerset Therapeutics Private Limited. The most recent is dated Sep 4, 2025, with the subject "CGMP/Finished Pharmaceuticals/Adulterated".
Has Somerset Therapeutics Private Limited received an FDA Form 483?
FDA has published 1 Form 483 for Somerset Therapeutics Private Limited in its reading room, the most recent dated Feb 21, 2025. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Somerset Therapeutics Private Limited?
The most recent FDA inspection on file ended Feb 21, 2025 at Bengaluru, India and was classified OAI. FDA has 10 inspections of Somerset Therapeutics Private Limited on file, 4 of them classified OAI (official action indicated).
Has Somerset Therapeutics Private Limited had an FDA recall?
Yes. Somerset Therapeutics Private Limited has 5 FDA recalls on record. The most recent under this name started Mar 21, 2025. A newer recall, dated Feb 4, 2026, is filed under the related name Somerset Therapeutics.
Need more than this page shows? Ask about Somerset Therapeutics Private Limited in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.